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Abstract
Objective: To evaluate the management of asthma attacks in children up to five years of age treated in the pediatric emergency room of a 
hospital in the metropolitan area of the city of Recife, Brazil, as well as to determine whether the way in which asthma attacks are managed 
can influence the duration of emergency room visits for such children. Methods: A descriptive, exploratory study employing a quantitative, 
cross-sectional approach. The study sample comprised 246 children treated for asthma attacks in an emergency room. The approach used 
was evaluated in comparison with the approach recommended in the III Brazilian Consensus on Asthma Management, as was the length 
of time each child spent in the emergency room. Results: In 69 (28.1%) of the cases, the medications were used in accordance with the 
Consensus guidelines. In 34 (13.8%) of the cases, the doses used were those recommended in the Consensus guidelines, and the guidelines 
regarding nebulization procedures were followed in 33 cases (13.4%). No correlation was found between the approach taken and the length 
of the emergency room visit. In the logistic regression analysis, we observed that the adjusted risk of being released from the emergency room 
sooner than recommended in the Consensus guidelines (a length of time sufficient to allow the response to the treatment to be analyzed) 
was four times and fifteen times greater, respectively, for children with mild persistent asthma and for those with intermittent asthma. 
Conclusion: Although there are obstacles to using the asthma management approach recommended in the Consensus guidelines (such 
obstacles including the lack of familiarity with the guidelines on the part of the multidisciplinary team, as well as the lack of recommended 
material and therapeutic resources), the duration of emergency room visits was found to be related to the degree of asthma severity. 
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Introduction
Among all of the countries in the world, Brazil 
presents the eighth highest frequency of asthma 
(20%),(1) which ranges from 4.% to 20.% among 
children between six and seven years of age.(2) In the 
city of Recife, Brazil, the results of the International 
Study of Asthma and Allergies in Childhood, in 
which 3086 adolescents between thirteen and four-
teen years of age and 1410 children between six and 
seven years of age were interviewed, revealed that 
20.9% and 20.4% of the interviewees, respectively, 
had a history of asthma.(3)
Guidelines and consensuses have been estab-
lished with the aim of orienting the diagnosis of 
bronchial asthma as well as of standardizing its 
evaluation and treatment approaches.(1-5) However, 
studies show great variability in the pattern of clin-
ical practice in the treatment of these patients, which 
interferes with the quality of the treatment.(6-) The 
advances in clinical approach within the past ten 
years have not been incorporated into the clinical 
practices used in treating most patients.(8) This can 
be demonstrated by the fact that constant visits to 
the emergency room continue, which presupposes 
inappropriate treatment.(9)
In the literature, the explanations for the increase 
in the rates of hospital admission for asthma are 
varied and controversial. Some studies offer expla-
nations such as the introduction of nebulization 
therapy in the 190s and the consequent increase 
in the emergency room availability of nebuliza-
tion;(10) low socioeconomic level and limited access 
of the low-income population to the health care 
system;(8) age bracket, especially the younger than 
five years of age bracket; inappropriate prophylactic 
treatment;(11) lack of regular follow-up treat-
ment of the disease;(12) as well as the increase in 
the prevalence and severity of the disease and its 
underdiagnosis.(13)
The relationship between inappropriate outpa-
tient approaches to the treatment of asthma in 
the frequent visits to the emergency room and the 
higher risk of serious or fatal asthma attacks is well-
known. However, for the low-income population in 
Brazil, the emergency room is often the principal or 
only means of access to the health care system.(14) 
In Brazil, 16% of the emergency room visits by chil-
dren are for acute asthma attacks.(15)
In 1999, questionnaires about the management 
and treatment of asthma patients in the country 
were completed by ten (50%) of the presidents 
of the regional councils of the Brazilian Thoracic 
Society. Inappropriate asthma management in low-
income patients was attributed to lack of appropriate 
medication, insufficient resources to purchase such 
medication, and functional difficulties related to 
public service.(16)
The objective of the present study was to iden-
tify the management of asthma attacks in children 
up to five years of age treated in an emergency 
room of a hospital in the greater metropolitan area 
of the city of Recife, Brazil, as well as to deter-
mine whether the way in which asthma attacks are 
managed can influence the duration of emergency 
room visits for such children. The guidelines estab-
lished in the 2002 III Brazilian Consensus on Asthma 
Management (BCAM) were used as parameters.
Methods
A descriptive, exploratory study employing a 
quantitative, exploratory approach was carried out 
in the pediatric and adult emergency room of a 
hospital in the city of Camaragibe (in the state of 
Pernambuco, Brazil) that treats Unified Health Care 
System patients exclusively.
The study sample comprised 246 children of 
up to five years of age, of both genders, diagnosed 
with asthma and treated in the emergency room 
between August and October of 2003. In addi-
tion, these children had a history of at least two 
previous episodes of dyspnea and wheezing, which 
were alleviated by bronchodilator use, and had 
been experiencing symptom exacerbations in the 
preceding days or hours. Children who, in addi-
tion to the asthma attack, presented accompanying 
physician-diagnosed infection, based on patient 
history and clinical evaluation, were excluded from 
the sample.
The instrument used for data collection consisted 
of a form on which the researcher recorded data 
regarding demographic factors (gender and age), 
the treatment given to each child, and the inten-
sity of the asthma attack, established in accordance 
with the III BCAM parameters. After the completion 
of the form, a questionnaire was administered to 
each parent or guardian in order to evaluate asthma 
severity. Although this is also in accordance with 
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the III BCAM, it might introduce a bias, since it 
depends on the memory of the guardians rather 
than on previous records.
The analysis variables, presented herein, were 
precoded using the designations ‘as recommended’ 
or ‘not as recommended’ in accordance with the 
criteria established in the III BCAM in its algorithm 
for the treatment of children presenting asthma 
attacks in the emergency room: factors related to 
the medications administered (medication doses, 
corticosteroid use in the first hour of treatment, 
and the use of anticholinergics); factors related to 
the nebulization therapy (use and control of oxygen 
flow); and duration of the emergency room visit.
The data were entered into a Microsoft Excel® 
(version 2000) database, and the Statistical Package 
for the Social Sciences (version 10.0) program was 
used to process and analyze the data. The test of 
independence (known as a measure of associa-
tion) was used in order to evaluate the relationship 
between each variable and the continuous variable 
‘duration of the visit’. Logistic regression was used 
to define the explanatory variables of the model.
The study design was approved by the Ethics 
in Research Committee of the Federal University 
of Pernambuco and was authorized by the admin-
istration of the institution. All parents, guardians 
or legal representatives of the same gave written 
informed consent.
Results
Of the 246 children studied, 116 (4.2%) were 
female and 130 (52.8%) were male. The highest 
number of visits occurred among children between 
one and three years of age (43.5%), and there were 
no visits by children under six months of age. None 
of the children underwent outpatient monitoring 
for treatment between asthma attacks. Clinical 
histories suggestive of intermittent asthma were 
identified in 112 (45.5%) of the children. During the 
crises, mild or moderate forms predominated in 206 
(83.%) of the cases, and the severe forms occurred 
less frequently (Table 1).
The medications available in the emergency 
room were fenoterol, ipratropium bromide, dexam-
ethasone (in suspension or in injectable form), 
and aminophylline. Fenoterol was used in all of 
the treatments. Ipratropium bromide was used in 
210 children, dexamethasone was used in 136 chil-
dren, and aminophylline was used in 4 children 
(Table 2).
The use of the medications was in accordance 
with the III BCAM in 69 (28.1%) of the cases. The 
doses of all of the medications administered were 
in accordance with the Consensus guidelines in 
34 (13.8%) of the cases. The route of administra-
tion of the corticosteroid used was in accordance 
with the Consensus guidelines in 6 (55.9%) of the 
136 cases. In 33 (13.4%) of the cases, the nebuliza-
tion procedure was performed using oxygen at a 
flow rate of 6 L/min (Table 2).
The doses of fenoterol used were those recom-
mended in the Consensus guidelines in 61 (24.8%) 
of the cases. Ipratropium bromide was used in 
210 procedures. However, there was only one case 
in which the dose was that recommended in the 
III BCAM. The results for corticosteroids refer to 
dexamethasone (in suspension or injectable), after 
the calculation of doses that were equivalent to the 
recommended doses of prednisone.(1) In 44 (32.4%) 
of the cases, doses that were equivalent to the 
recommended doses of prednisone were observed 
(Table 2).
Table 1 - Distribution of the sample by gender, age, 
asthma severity and intensity of asthma attacks, 
Camaragibe - Brazil.
Variable n %
Gender
Female 116 4.2
Male 130 52.8
Total 246 100.0
Age (years)a
≤ 1  31.3
> 1-3 10 43.5
> 3-5 62 25.2
Total 246 100.0
Type/Severity of Asthma
Intermittent 112 45.5
Persistent/Mild 61 24.8
Persistent/Moderate 61 24.8
Persistent/Severe 12 4.9
Total 246 100.0
Intensity of Asthma Attack
Mild or Moderate 206 83.
Serious 36 14.6
Very Serious 4 1.
Total 246 100.0
*median, 2 years.
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The use of oxygen and the flow rate recom-
mended in the III BCAM were observed in 83 (33.%) 
of the cases. However, the recommended nebuliza-
tion protocol (one nebulization every 20 min for the 
first hour) was followed in only 33 (13.4%) of the 
procedures (Table 2).
The test of independence for the association 
between the duration of emergency room visits and 
the other variables separately (Table 3) suggests 
that the duration of emergency room visits is asso-
ciated with corticosteroid use in the first hour, as 
well as with the intensity of the asthma attack and 
the degree of asthma severity (p < 0.05).
In the study model (logistic regression), when 
the test of independence was carried out by cross-
referencing the duration of emergency room visits 
and the other variables separately, it was found that 
only the intensity of the asthma attack and the 
degree of asthma severity remained in the model, 
being related to the duration of the visit.
In the logistic regression analysis, we observed 
that the risk of being released from the emergency 
Table 2 - Adoption of approaches recommended in the III BCAM for the treatment of asthma attacks in children up 
to five years of age regarding the therapeutic resources used, Camaragibe-Brazil.
Therapeutic resources Recommended n (%) Not recommended n (%) Total n (%)
Medication used 69 (28.1) 1 (1.9) 246 (100.0)
Fenoterol 246 (100.0) 0 (0.0) 246 (100.0)
Ipratropium bromide 3 (1.6) 13 (82.4) 210 (100.0)
Corticosteroida 69 (50.) 6 (49.3) 136 (100.0)
Aminophylline 0 (0.0) 4 (100.0)  4 (100.0)
Doses 34 (13.8) 212 (86.2) 246 (100.0)
Fenoterol 61 (24.8) 185 (5.2) 246 (100.0)
Ipratropium bromide 1 (0.5) 209 (99.5) 210 (100.0)
Corticosteroida 44 (32.4) 92 (6.6) 136 (100.0)
Route of administrationb 6 (55.9) 60 (44.1) 136 (100.0)
Nebulization procedurec 33 (13.4) 213 (86.6) 246 (100.0) 
aThe corticosteroid available in the emergency room was dexamethasone (in suspension or injectable), whose doses were estimated 
to be equivalent to the recommended doses of prednisone(1); bData related to corticosteroid administration; cFor the nebulization 
procedure to be considered the recommended procedure, the use of oxygen, the control of its flow, and the intervals between nebuli-
zations had to be in accordance with the III BCAM.
Table 3 - Distribution of the variables regarding the length of time each child spent in the emergency room, 
Camaragibe-Brazil.
Variable Length of time spent in the emergency room
As recommended n (%) Not as recommended n (%) p value
Type of asthma/degree of severity < 0.001
Persistent/moderate or severe 51 (20.) 21 (8.5)
Persistent/mild 18 (.3) 44 (1.9)
Intermittent 11 (4.5) 101 (41.1)
Intensity of the asthma attack < 0.001
Serious or Very serious 28 (11.4) 12 (4.9)
Mild or Moderate 51 (20.) 155 (63.0)
Use and control of oxygen flow in nebulizations 0.363
Not as recommended 49 (19.9) 115 (46.8)
As recommended 30 (12.2) 52 (21.1)
Corticosteroids in the first hour 0.004
Not as recommended 26 (10.6) 93 (3.8)
As recommended 51 (20.) 6 (30.9)
Use of anticholinergics 0.136
Not as recommended 50 (20.3) 123 (50.0)
As recommended 29 (11.8) 44 (1.9)
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room sooner than necessary to allow the response to 
the treatment to be analyzed was four times greater 
for children with mild persistent asthma (OR = 4.1) 
and fifteen times greater for children with intermit-
tent asthma (OR = 15.65) than for children with 
moderate persistent asthma and those with severe 
persistent asthma (Table 4).
With regard to the intensity of the asthma 
attack, the adjusted risk of being discharged from 
the emergency room sooner than recommended in 
the III BCAM (a length of time sufficient to allow 
the monitoring and evaluation of the attack) was 
approximately two-times greater (OR = 2.56) for the 
206 children (83.%) that presented asthma attacks 
of mild or moderate intensity (Table 4).
Discussion
The present study sought to evaluate the use 
of the approaches recommended in the III BCAM 
in pediatric cases treated in the emergency room 
and its repercussions on the duration of emergency 
room visits. The medications and the nebulization 
procedures were checked.
The results reveal that, in the 246 cases surveyed, 
there was a slight predominance of male children, 
130 (52.8%), as well as of the 0–3 years of age 
bracket.(18) The asthma was classified as intermittent 
in 112 (45.5%) of the cases, and the intensity of the 
asthma attack was classified as mild or moderate in 
206 (83.%). We observe that the milder forms of 
presentation both of the disease and of the intensity 
of the asthma attack prevailed.(18,19) These data are 
important for the analysis of the approach regarding 
the use of corticosteroids and anticholinergics in the 
emergency room.
The present study shows that the use of medi-
cations was in accordance with the Consensus 
guidelines(1-4) (β2-agonists and anticholinergics), 
except for the fact that xanthines, which are not 
recommended for use(1-4) in the emergency room, 
were used in four cases in which the children were 
found to be refractory to treatment and had spent 
more than five hours in the emergency room. It is 
noteworthy that the dose used was 3 mg/kg, which 
is the lowest therapeutic intravenous loading dose, 
since it was not possible to determine the serum 
concentrations of theophylline.(15)
Although the three groups of drugs chosen 
for the treatments were in accordance with the 
Consensus guidelines,(1-4) the same did not occur 
with regard to their form of use, such as the use 
of anticholinergics for mild and moderate asthma 
attacks, corticosteroid use in the first hour in 
non-corticosteroid-dependent patients, and the 
use of aminophylline, which were responsible for 
1 (1.9%) of the non-recommended proce-
dures.(1-4) There was, however, no association with 
the length of time each child spent in the emer-
gency room (Table 2).
Even though β2-agonists were used in all cases, 
as recommended in the Consensus guidelines, in 
185 (5.2%) of the cases, the doses were not admin-
istered at the recommended rate of 0.1 mg/kg.(1-4) 
This high number of cases in which the dose was 
lower than that recommended in the Consensus 
guidelines is probably due to the fact that the 
doses were determined at the rate of one drop per 
three kilograms of body weight, which is endorsed 
by some authors(20) and is in accordance with the 
manufacturer recommendation.(21)
Table 4 - Multivariate analysis of the variables studied regarding the length of time each child spent in the emergency 
room, Camaragibe-Brazil.
Type of asthma/degree of severity Unadjusted OR (95% CI) p Adjusted OR (95% CI) p
Moderate and Severe persistent 1.00 1.00
Mild persistent 5.54 < 0.001 4.1 < 0.001
Intermittent 21.28 < 0.001 15.65 < 0.001
Intensity of the asthma attack
Severe or Very severe 1.00 1.00
Mild or Moderate 6.91 < 0.001 2.56 < 0.04
Corticosteroid in the first hour
Not as Recommended 1.00 1.00
As Recommended 0.44 0.004 0.8 0.49
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The recommended dose(1) of the anticholinergic 
agent ipratropium bromide ranges from 250 µg 
to 500 µg. However, the doses were lower than 
250 µg in 209 (99.5%) of the 210 cases in which 
this drug was used. It is important to highlight that, 
in 19 cases, the doses ranged from 100 to 249 µg, 
in consonance with the manufacturer recommenda-
tion,(21) in which doses range from 0.1 a 0.25 mg 
for children under six years of age. Although it is 
recommended(1) that ipratropium bromide be used 
in combination with β2-agonists in serious asthma 
attacks, ipratropium bromide was administered to 
10 children presenting mild or moderate asthma 
attacks, whereas 3 children presenting serious or 
very serious asthma attacks did not receive it.
In a study published in 1998 and involving 
434 children,(22) it was concluded that the addi-
tion of ipratropium bromide to treat serious 
asthma attacks reduces the need for hospitalization 
significantly (from 53% to 38%). However, a quite 
different perspective was provided by a systematic 
review published in the same year.(23) The authors 
of that review evaluated four studies involving chil-
dren or adolescents and did not identify any benefit 
of the use of ipratropium bromide in the treatment 
of mild or moderate asthma attacks. It is important 
to highlight that, in Brazil, ipratropium bromide is 
approximately ten times more expensive than fenot-
erol.(24) Therefore, it should be used judiciously in 
the treatment of mild and moderate asthma attacks, 
considering the optimization of the use of medica-
tions as well as the impact on hospital costs.
The corticosteroid available in the emergency 
room was dexamethasone (suspension or inject-
able form). In 60 (44.1%) of the 136 cases in which 
dexamethasone was used, the route of administra-
tion (Table 2) was not that recommended in the 
Consensus guidelines.(1-4) Intramuscular adminis-
tration, which is not usually recommended for use 
in children, since corticosteroids with long-term 
release present erratic absorption and considerable 
individual variability when administered intramus-
cularly,(25-26) was responsible for this number. In fact, 
only  children presented vomiting, which justi-
fied the use of intramuscular administration. In the 
other cases in which the drug was used, it could 
have been administered orally in accordance with 
the Consensus guidelines, and this could have mini-
mized the number of invasive procedures, as well as 
the costs related to materials and to the number of 
hours of nursing care.
The analysis of the doses of dexamethasone 
administered was impeded because such doses were 
estimated based on their equivalence to those recom-
mended for intermediate half-life corticosteroids.(25)
The doses used for pediatric patients are usually 
based on clinical studies involving adults, which are 
justified by ethical constraints on clinical research 
involving children. These studies are the pharma-
cotherapeutic basis for the estimation of pediatric 
doses, and it is common that doses recommended 
can be modified according to clinical practice. Some 
English-speaking authors state that the definition 
of the word ‘children’ itself can be an impediment 
to the estimation of therapeutic doses since the 
term would include all individuals from newborns 
to adolescents. Therefore, in the attempt to guide 
prescriptions in clinical practice, the Licensing 
Medicines for Children Report of May 1996, which 
was based on studies carried out by the British 
Paediatric Association and by the Association of 
the British Pharmaceutical Industry, delimited the 
age brackets that must be considered, as well as the 
relationship between age and weight and, in some 
cases, between age and body area.(2)
In 33 (13.4%) of the cases, the nebuliza-
tion procedure used was in accordance with the 
Consensus guidelines(1) (Table 2). The procedure 
should be performed using oxygen at a minimum 
flow rate of 6 L/min and at 20 min intervals in the 
first hour of treatment.(1) This protocol was followed 
in only 83 (33.%) of the nebulizations used for 
the administration of β2-agonists (with or without 
anticholinergics), although the emergency room 
provided resources for the use of oxygen in all of 
the cases. We observed that oxygen, as well as the 
oxygen flow rate of 6 L/min, were only used when 
prescribed on the patient chart.
It is essential that oxygen be used in the nebuli-
zation therapy in order to protect patients from the 
possible deleterious effects of the combination of 
hypoxemia and the use of β2-agonists, which can 
have a direct impact on the cardiovascular system.(28) 
In order to convert the solution into a nebulized 
aerosol containing particles between 2 and 4 µ, 
the oxygen flow rate should be between 6 and 
9 L/min.(29)
The protocol of three nebulizations at 20 min 
intervals in the first hour was followed in 33 (13.4%) 
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of the cases, in which cases the procedure was 
properly prescribed. In the other 213 procedures 
(86.6%), the intervals between nebulizations varied 
in duration.
Table 3 shows that, in the less critical pres-
entations in terms of the type of asthma and the 
intensity of the asthma attack, represented respec-
tively by 101 cases of intermittent asthma (41.1%) 
and by 155 cases of mild or moderate asthma attacks 
(63%), in which the duration of the emergency room 
visit was not in accordance with the III BCAM, the 
result was essentially determined by the non-moni-
toring of the child for at least an hour after a good 
response to the treatment instituted. This “early” 
discharge from the emergency room may result in 
frequent subsequent emergency room visits or even 
in the “underestimation” of the child asthma attack 
on the part of the family, which makes it difficult to 
identify any signs of worsening at home.
In the more critical clinical situations – in 
51 cases of patients with moderate or severe 
persistent asthma (20.%) and in 28 cases of 
serious or very serious asthma attacks (11.4%) – the 
III BCAM parameters were observed in terms of the 
duration of the emergency room visits. These differ-
ences were statistically significant (Table 3).
Corticosteroid use in the first hour of treatment 
was found to be associated with the duration of 
emergency room visit since corticosteroid use in the 
emergency room is possibly related to more serious 
crises, in which the results regarding the observation 
of the approaches recommended in the Consensus 
guidelines were better (Table 3). This result was 
statistically confirmed (p = 0.004).
A recent study(30) reported the results of the 
implementation of a protocol for the emergency 
room treatment of adults with asthma attacks. 
Despite the positive effects of this protocol on 
the treatment given to patients, which led to an 
increase in the use of peak expiratory flow deter-
mination, pulse oximetry, administration of three 
nebulizations in the first hour of treatment, and 
oral corticosteroid therapy, there was no significant 
effect on the duration of emergency room visits or 
on the rates of admission and discharge.
It should be stressed that there were deficiencies 
in the emergency room that might have hindered 
the adoption of the approaches recommended in 
the III BCAM, such as the lack of a pulse oximeter 
for the objective evaluation of the treatment as 
well as the non-availability of the corticosteroid 
recommended.
The staff of emergency rooms includes multi-
disciplinary teams, of which specialists are not 
necessarily part. In emergency rooms, the adoption 
of treatment guidelines can be a facilitator for work 
in an environment where the routine frequently 
includes work overload, need for quick decision 
making, lack of standardization of procedures, and 
limited communication among the various members 
of the team.
Systematic protocols for the treatment of asthma 
attacks in the emergency room can contribute 
to the process of continuing education, with the 
objective of improving the quality of health care. It 
should also be borne in mind that the time saved 
in making certain decisions can be important for a 
holistic, humanized treatment of patients. Protocols 
should include some educational measures designed 
to reduce the number of visits to the emergency 
room, which, for asthma patients, is quite often the 
entryway – or the only means of access – to health 
care.(14)
The length of time children with mild asthma 
attacks and those with moderate asthma attacks 
spent in the emergency room was shorter than that 
recommended in the III BCAM; the minimum one-
hour interval after a good response to treatment 
required for the profile to be considered stable, 
thereby allowing discharge, was not observed.
In conclusion, we found that there are various 
obstacles to the implementation of the approaches 
recommended in the III BCAM. Such obstacles 
include limited familiarity with the Consensus 
guidelines on the part of the multidisciplinary team, 
as well as the lack of recommended material and 
therapeutic resources (pulse oximeters and interme-
diate-release corticosteroids).
We recommend that the III BCAM be more 
widely disseminated in academic environments and 
continuing education centers, as well as in emer-
gency rooms, due to the significance of the role 
played by those sectors as vehicles of information 
transfer to multidisciplinary teams and the general 
population. The democratization of this informa-
tion can lead to the taking of measures designed 
to optimize the allocation of resources, such as the 
purchase of the recommended medications, as well 
as increasing the availability of pulse oximeters and 
peak expiratory flow meters in emergency rooms, 
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all of which can ultimately improve the quality of 
health care.
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